ISRAEL – LionBird, a Tel Aviv, Israel- and Chicago, IL-based venture capital firm investing in pre-scale digital health companies, closed LionBird III, at $85m.
The fund was supported by several institutional investors, including the Healthcare of Ontario Pension Plan (HOOPP), and leading industry executives. With this new fund, LionBird will invest in 15 to 20 early-stage companies within its core theme of digital health. Founded in 2012, the firm has invested in more than 30 founding teams across the U.S. and Israel, including digital health leaders such as Tyto Care, Ovia Health (acquired by LabCorp), C2i Genomics, Assured Allies, Protenus, Kit Check, Theranica, Laguna Health and Rhino Health.To bolster these efforts in LionBird III, the fund has expanded its investment team with the addition of two new partners: Robert Lord, previously co-founder and President at Protenus, a leading AI health IT compliance company from LionBird’s second fund, and Gal Noyman-Veksler, PhD, a healthcare AI business executive and a venture experienced behavioral researcher, who was promoted from principal. They join partners Ed Michael, Chaim Friedman, and Jonathan Friedman. 11/04/2022
